Review of intranasal influenza vaccine (Q34343302)

1 August 2017

Review of intranasal influenza vaccine (English)

1 reference

1 August 2017

1 reference

Glueck R

1

1 reference

PubMed ID

11516789

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

1 reference

1 August 2017

51

1 reference

1 August 2017

1-3

1 reference

1 August 2017

203-211

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

1 August 2017

1 reference

7 January 2021

Determinants of immunity to influenza infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Influenza: its control in persons and populations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

[Vaccination against influenza in Switzerland]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Influenza vaccination in 22 developed countries: an update to 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Zanamivir: a review of its use in influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Liposomal influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

Mucosal immunity and vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900174-0

7 January 2021

10.1016/S0169-409X(01)00174-0

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11516789